quinoxalines has been researched along with Cerebral Infarction in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 18 (72.00) | 18.2507 |
| 2000's | 7 (28.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chua, BH; Chua, CC; Chua, KW; Gao, J; Hamdy, RC; Wang, H; Xu, X | 1 |
| Bazan, NG; de Turco, EB; Diemer, NH; Kolko, M | 1 |
| Miyata, K; Sasamata, M; Suzuki, M | 1 |
| Hashimoto, K; Nakamura, R; Suzuki, Y; Takagi, Y; Umemura, K | 1 |
| Akino, H; Komatsu, K; Mizuno, H; Namiki, M; Tanase, K; Yokoyama, O | 1 |
| Barnes, KA; Buchan, AM; Huang, ZG; Lesiuk, H; Li, H; Smith, KE; Xue, D | 1 |
| Barnes, K; Buchan, AM; Huang, ZG; Lesiuk, HJ; Smith, KE; Xue, D | 1 |
| Boysen, G; Overgaard, K; Pedersen, H; Sereghy, T | 1 |
| Hossmann, KA; Kohno, K; Mies, G | 1 |
| Boysen, G; Meden, P; Overgaard, K; Sereghy, T | 1 |
| Christensen, T; Diemer, NH; Jørgensen, MB | 1 |
| Chen, J; Graham, SH; Lan, JQ; Simon, RP | 1 |
| Hatanaka, K; Kawasaki-Yatsugi, S; Koshiya, K; Murase, K; Ohmori, J; Okada, M; Sakamoto, S; Shimizu-Sasamata, M; Togami, J; Usuda, S; Yatsugi, S | 1 |
| Bart, RD; Brinkhous, A; Pearlstein, R; Takaoka, S; Warner, DS | 1 |
| Lo, EH; Mandeville, JB; Pierce, AR; Rosen, BR | 1 |
| Cai, H; Fujishima, M; Ibayashi, S; Nakane, H; Uchimura, H; Yao, H | 1 |
| Nakashima, M; Shimakura, A; Umemura, K | 1 |
| Ichiki, C; Kawasaki-Yatsugi, S; Minematsu, K; Shimizu-Sasamata, M; Takahashi, M; Toya, T; Yamaguchi, T; Yatsugi, S | 1 |
| Craddock, SD; Geddes, JW; Holtz, ML; Minger, SL; Pettigrew, LC; Siman, RG; Whiteheart, SW | 1 |
| Ichiki, C; Kawasaki-Yatsugi, S; Shimizu-Sasamata, M; Yamaguchi, T; Yatsugi, S | 1 |
| Ni, JW; Shimizu-Sasamata, M; Takahashi, M; Yamaguchi, T; Yatsugi, S | 1 |
| Haapalinna, A; Jolkkonen, J; Kauppinen, R; Koistinaho, J; Nieminen, L; Puurunen, K; Sivenius, J | 1 |
| Cole, DJ; Drummond, JC; Kelly, PJ; Kimbro, JR; Patel, PM | 1 |
| Besozzi, C; Bonali, P; Borsini, F; Brambilla, A; Fodritto, F; Grippa, N; Pitsikas, N; Scandroglio, A | 1 |
| Buchan, AM; Huang, ZG; Lesiuk, H; Smith, KH; Xue, D | 1 |
25 other study(ies) available for quinoxalines and Cerebral Infarction
| Article | Year |
|---|---|
Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathway.
Topics: Androstadienes; Animals; Benzylamines; Blotting, Western; Brain; Brain Ischemia; Cell Death; Cell Hypoxia; Cell Survival; Cells, Cultured; Cerebral Infarction; Glucose; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Male; Mice; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinoxalines; Reperfusion Injury; Signal Transduction; Wortmannin | 2008 |
Secretory phospholipase A2-mediated neuronal cell death involves glutamate ionotropic receptors.
Topics: Animals; Arachidonic Acid; Astrocytes; Body Temperature; Brain; Cell Death; Cells, Cultured; Cerebral Infarction; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Fetus; Group II Phospholipases A2; Humans; Neostriatum; Neurons; Phospholipases A; Phospholipases A2; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2002 |
Neuroprotective effects of YM872 coadministered with t-PA in a rat embolic stroke model.
Topics: Animals; Carotid Artery Thrombosis; Cerebral Infarction; Fibrinolytic Agents; Imidazoles; Infusions, Intravenous; Male; Models, Animal; Motor Activity; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Tissue Plasminogen Activator | 2003 |
Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats.
Topics: Aging; Animals; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Infarction, Middle Cerebral Artery; Kainic Acid; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Telencephalon | 2003 |
Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat.
Topics: Animals; Cerebral Infarction; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Glutamate; Urinary Bladder Diseases | 2004 |
AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Benzodiazepines; Cerebral Infarction; Cerebrovascular Disorders; Dizocilpine Maleate; Drug Administration Schedule; Injections, Intraperitoneal; Male; N-Methylaspartate; Quinoxalines; Rats; Rats, Wistar; Reperfusion | 1993 |
Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Benzodiazepines; Cerebral Cortex; Cerebral Infarction; Cerebrovascular Circulation; Injections, Intraperitoneal; Injections, Intravenous; Kidney; Male; N-Methylaspartate; Pilot Projects; Quinoxalines; Rats; Rats, Inbred SHR; Sodium Chloride | 1994 |
Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke.
Topics: Animals; Brain Edema; Cerebral Infarction; Cerebrovascular Circulation; Fibrinolysis; Intracranial Embolism and Thrombosis; Male; Paralysis; Quinoxalines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator; Weight Loss | 1993 |
Prevention of periinfarct direct current shifts with glutamate antagonist NBQX following occlusion of the middle cerebral artery in the rat.
Topics: Animals; Brain; Cerebral Arteries; Cerebral Infarction; Electroencephalography; Electrophysiology; Male; Quinoxalines; Rats; Receptors, AMPA | 1994 |
Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model.
Topics: Animals; Blood Pressure; Cerebral Angiography; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascular Disorders; Fibrinolytic Agents; Intracranial Embolism and Thrombosis; Male; Plasminogen Activators; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1993 |
Impairment of Fos protein formation in the rat infarct borderzone by MK-801, but not by NBQX.
Topics: Animals; Cerebral Cortex; Cerebral Infarction; Corpus Striatum; Cortical Spreading Depression; Dizocilpine Maleate; Energy Metabolism; Gene Expression Regulation; Male; Neurons; Proto-Oncogene Proteins c-fos; Quinoxalines; Rats; Rats, Inbred SHR; Receptors, N-Methyl-D-Aspartate | 1993 |
A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
Topics: Animals; Brain; Brain Ischemia; Cerebral Arteries; Cerebral Infarction; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Heat-Shock Proteins; Male; N-Methylaspartate; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1996 |
YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
Topics: Animals; Anticonvulsants; Brain Ischemia; Cerebral Infarction; Corpus Striatum; Gerbillinae; Ischemia; Male; Mice; Mice, Inbred DBA; Quinoxalines; Radioligand Assay; Rats; Rats, Inbred F344; Rats, Wistar; Receptors, AMPA; Receptors, Kainic Acid; Seizures | 1996 |
Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
Topics: Animals; Binding Sites; Brain Damage, Chronic; Brain Ischemia; Cerebral Infarction; Excitatory Amino Acid Antagonists; Fever; Glycine; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Temperature | 1997 |
Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships.
Topics: Animals; Body Water; Brain Damage, Chronic; Brain Edema; Brain Ischemia; Cerebral Infarction; Diffusion; Excitatory Amino Acid Antagonists; Magnetic Resonance Imaging; Male; Nerve Tissue Proteins; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1997 |
AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats.
Topics: Animals; Arterial Occlusive Diseases; Cerebral Infarction; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Hypertension; Intracranial Embolism and Thrombosis; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred SHR; Receptors, AMPA | 1997 |
Neuroprotective effect of a novel AMPA receptor antagonist, YM90K, in rat focal cerebral ischaemia.
Topics: Animals; Cerebral Arteries; Cerebral Cortex; Cerebral Infarction; Corpus Striatum; Endothelium, Vascular; Excitatory Amino Acid Antagonists; Ischemic Attack, Transient; Male; Neuroprotective Agents; Platelet Adhesiveness; Platelet Aggregation; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA | 1997 |
A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.
Topics: Animals; Arterial Occlusive Diseases; Blood Gas Analysis; Body Temperature; Brain; Brain Ischemia; Cerebral Arteries; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Infusions, Intravenous; Kidney; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Time Factors | 1998 |
Glutamate receptor antagonists inhibit calpain-mediated cytoskeletal proteolysis in focal cerebral ischemia.
Topics: Animals; Blotting, Western; Calpain; Cerebral Infarction; Cytoskeleton; Excitatory Amino Acid Antagonists; Immunohistochemistry; Ischemic Attack, Transient; Male; Microtubule-Associated Proteins; Pipecolic Acids; Quinoxalines; Rats; Rats, Inbred SHR; Receptors, Glutamate; Spectrin; Synaptic Transmission; tau Proteins | 1998 |
YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats.
Topics: Animals; Arterial Occlusive Diseases; Brain; Brain Ischemia; Cerebral Arteries; Cerebral Infarction; Male; Neuroprotective Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA | 1998 |
Effects of YM872 on atrophy of substantia nigra reticulata after focal ischemia in rats.
Topics: Animals; Arterial Occlusive Diseases; Atrophy; Body Temperature; Body Weight; Brain Ischemia; Cerebral Infarction; Imidazoles; Male; Neurologic Examination; Neuroprotective Agents; Quinoxalines; Rats; Rats, Inbred F344; Receptors, AMPA; Substantia Nigra | 1998 |
Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia.
Topics: Adrenergic alpha-Agonists; Animals; Arterial Occlusive Diseases; Body Weight; Cerebral Arteries; Cerebral Cortex; Cerebral Infarction; Corpus Striatum; Excitatory Amino Acid Antagonists; Imidazoles; Ischemic Attack, Transient; Male; Medetomidine; Neuroprotective Agents; Pipecolic Acids; Quinoxalines; Rats; Rats, Wistar | 1999 |
Isoflurane and pentobarbital reduce AMPA toxicity in vivo in the rat cerebral cortex.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anesthetics, Inhalation; Animals; Blood Pressure; Cerebral Cortex; Cerebral Infarction; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; GABA Modulators; Heart Rate; Image Processing, Computer-Assisted; Isoflurane; Necrosis; Pentobarbital; Quinoxalines; Rats; Rats, Inbred WKY; Receptors, AMPA | 2000 |
Effects of cerestat and NBQX on functional and morphological outcomes in rat focal cerebral ischemia.
Topics: Animals; Behavior, Animal; Brain; Cerebral Infarction; Excitatory Amino Acid Antagonists; Forelimb; Guanidines; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Neuroprotective Agents; Physical Stimulation; Proprioception; Psychomotor Performance; Quinoxalines; Rats; Rats, Inbred F344; Vibrissae | 2001 |
Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia.
Topics: Animals; Blood Pressure; Carbon Dioxide; Cerebral Infarction; Cerebrovascular Circulation; Ischemic Attack, Transient; Male; Oxadiazoles; Oxygen; Partial Pressure; Quinoxalines; Rats; Rats, Inbred SHR; Receptors, AMPA; Receptors, Neurotransmitter | 1991 |